<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan MC</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>Caroline Wiess Law Fund for Research in Molecular Medicine</funding><funding>U.S. Department of Veterans Affairs</funding><pagination>4500-4508</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9117573</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67(9)</volume><pubmed_abstract>&lt;h4>Background/aims&lt;/h4>Screening for gastric intestinal metaplasia (GIM) may lead to early gastric cancer detection. We developed and validated a pre-endoscopy risk prediction model for detection of GIM based on patient-level risk factors in a U.S.&lt;h4>Population&lt;/h4>&lt;h4>Methods&lt;/h4>We used data from 423 GIM cases and 1796 controls from a cross-sectional study among primary care and endoscopy clinic patients at the Houston VA. We developed the model using backwards stepwise regression and assessed discrimination using area under the receiver operating characteristic (AUROC). The model was internally validated using cross-validation and bootstrapping. The final expanded model was compared to a model including H. pylori infection alone and a baseline model including remaining terms without H</pubmed_abstract><journal>Digestive diseases and sciences</journal><pubmed_title>Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.</pubmed_title><pmcid>PMC9117573</pmcid><funding_grant_id>CIN 13-413</funding_grant_id><funding_grant_id>P30 DK056338</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Thrift AP</pubmed_authors><pubmed_authors>Tan MC</pubmed_authors><pubmed_authors>Nguyen TH</pubmed_authors><pubmed_authors>El-Serag HB</pubmed_authors><pubmed_authors>Ho Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.</name><description>&lt;h4>Background/aims&lt;/h4>Screening for gastric intestinal metaplasia (GIM) may lead to early gastric cancer detection. We developed and validated a pre-endoscopy risk prediction model for detection of GIM based on patient-level risk factors in a U.S.&lt;h4>Population&lt;/h4>&lt;h4>Methods&lt;/h4>We used data from 423 GIM cases and 1796 controls from a cross-sectional study among primary care and endoscopy clinic patients at the Houston VA. We developed the model using backwards stepwise regression and assessed discrimination using area under the receiver operating characteristic (AUROC). The model was internally validated using cross-validation and bootstrapping. The final expanded model was compared to a model including H. pylori infection alone and a baseline model including remaining terms without H</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T20:41:33.757Z</modification><creation>2025-04-04T20:41:33.757Z</creation></dates><accession>S-EPMC9117573</accession><cross_references><pubmed>34797447</pubmed><doi>10.1007/s10620-021-07309-3</doi></cross_references></HashMap>